Literature DB >> 35298299

Splicing and Dicing: A Deeper Dive Into CaMKIIδ and Cardiac Inflammation.

Joan Heller Brown1, Shigeki Miyamoto1.   

Abstract

Entities:  

Keywords:  Editorials; calcium-calmodulin-dependent protein kinase type 2; cell death; inflammation

Mesh：

Substances：

Year:  2022        PMID： 35298299      PMCID： PMC8944245          DOI： 10.1161/CIRCRESAHA.122.320881

Source DB:  PubMed          Journal:  Circ Res        ISSN： 0009-7330            Impact factor:   17.367


× No keyword cloud information.
  15 in total

1.  Inflammation and NLRP3 Inflammasome Activation Initiated in Response to Pressure Overload by Ca2+/Calmodulin-Dependent Protein Kinase II δ Signaling in Cardiomyocytes Are Essential for Adverse Cardiac Remodeling.

Authors:  Takeshi Suetomi; Andrew Willeford; Cameron S Brand; Yoshitake Cho; Robert S Ross; Shigeki Miyamoto; Joan Heller Brown
Journal:  Circulation       Date:  2018-11-27       Impact factor: 29.690

2.  Differentiation-dependent expression of cardiac delta-CaMKII isoforms.

Authors:  B Hoch; H Haase; W Schulze; D Hagemann; I Morano; E G Krause; P Karczewski
Journal:  J Cell Biochem       Date:  1998-02-01       Impact factor: 4.429

3.  CaMKIIδ subtypes differentially regulate infarct formation following ex vivo myocardial ischemia/reperfusion through NF-κB and TNF-α.

Authors:  Charles B B Gray; Takeshi Suetomi; Sunny Xiang; Shikha Mishra; Erik A Blackwood; Christopher C Glembotski; Shigeki Miyamoto; B Daan Westenbrink; Joan Heller Brown
Journal:  J Mol Cell Cardiol       Date:  2017-01-07       Impact factor: 5.000

4.  CaMKII-δ9 promotes cardiomyopathy through disrupting UBE2T-dependent DNA repair.

Authors:  Mao Zhang; Hua Gao; Dairu Liu; Xiaoming Zhong; Xiaolu Shi; Peng Yu; Li Jin; Yun Liu; Yajie Tang; Yunhu Song; Jinghao Liu; Xinli Hu; Chuan-Yun Li; Lei Song; Jun Qin; Fujian Wu; Feng Lan; Yan Zhang; Rui-Ping Xiao
Journal:  Nat Cell Biol       Date:  2019-09-02       Impact factor: 28.824

5.  CaMKIIδ-mediated inflammatory gene expression and inflammasome activation in cardiomyocytes initiate inflammation and induce fibrosis.

Authors:  Andrew Willeford; Takeshi Suetomi; Audrey Nickle; Hal M Hoffman; Shigeki Miyamoto; Joan Heller Brown
Journal:  JCI Insight       Date:  2018-06-21

6.  Ca2+/Calmodulin-dependent protein kinase II δ mediates myocardial ischemia/reperfusion injury through nuclear factor-κB.

Authors:  Haiyun Ling; Charles B B Gray; Alexander C Zambon; Michael Grimm; Yusu Gu; Nancy Dalton; Nicole H Purcell; Kirk Peterson; Joan Heller Brown
Journal:  Circ Res       Date:  2013-02-06       Impact factor: 17.367

7.  Critical role of nuclear calcium/calmodulin-dependent protein kinase IIdeltaB in cardiomyocyte survival in cardiomyopathy.

Authors:  Gillian H Little; Aman Saw; Yan Bai; Joan Dow; Paul Marjoram; Boris Simkhovich; Justin Leeka; Larry Kedes; Robert A Kloner; Coralie Poizat
Journal:  J Biol Chem       Date:  2009-07-14       Impact factor: 5.157

8.  Ca2+/calmodulin-dependent kinase II triggers cell membrane injury by inducing complement factor B gene expression in the mouse heart.

Authors:  Madhu V Singh; Ann Kapoun; Linda Higgins; William Kutschke; Joshua M Thurman; Rong Zhang; Minati Singh; Jinying Yang; Xiaoqun Guan; John S Lowe; Robert M Weiss; Kathy Zimmermann; Fiona E Yull; Timothy S Blackwell; Peter J Mohler; Mark E Anderson
Journal:  J Clin Invest       Date:  2009-03-09       Impact factor: 14.808

9.  Inducible cardiomyocyte-specific deletion of CaM kinase II protects from pressure overload-induced heart failure.

Authors:  Michael M Kreusser; Lorenz H Lehmann; Nora Wolf; Stanislav Keranov; Andreas Jungmann; Hermann-Josef Gröne; Oliver J Müller; Hugo A Katus; Johannes Backs
Journal:  Basic Res Cardiol       Date:  2016-09-28       Impact factor: 17.165

10.  CaM Kinase II mediates maladaptive post-infarct remodeling and pro-inflammatory chemoattractant signaling but not acute myocardial ischemia/reperfusion injury.

Authors:  Martin Weinreuter; Michael M Kreusser; Jan Beckendorf; Friederike C Schreiter; Florian Leuschner; Lorenz H Lehmann; Kai P Hofmann; Julia S Rostosky; Nathalie Diemert; Chang Xu; Hans Christian Volz; Andreas Jungmann; Alexander Nickel; Carsten Sticht; Norbert Gretz; Christoph Maack; Michael D Schneider; Hermann-Josef Gröne; Oliver J Müller; Hugo A Katus; Johannes Backs
Journal:  EMBO Mol Med       Date:  2014-10       Impact factor: 12.137
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.